Artigo - Atena Editora

Artigo

Baixe agora

Livros

INTERCONNECTIONS BETWEEN ERECTILE DYSFUNCTION AND METABOLIC DISEASES: AN INTEGRATIVE ANALYSIS

Objective: To evaluate the relationship between erectile dysfunction (ED) and metabolic diseases, exploring how metabolic factors affect the occurrence of ED. Methodology: Using PVO approach, the search was conducted in the PubMed Central database. The initial selection of 44 articles was refined to14after applying the inclusion and exclusion criteria. Studies have highlighted a two-way interaction between prediabetes/type 2 diabetes (T2D) and ED, with testosterone deficiency as a common factor. Revision: Identifying ED using the International Index of Erectile Function-5 (IIEF-5) is vital for effective treatment. Therapeutic strategies include phosphodiesterase type 5 inhibitors, hormonal therapy and lifestyle changes aimed at improving erectile function and metabolic and cardiovascular control. Final Considerations: This review emphasizes the importance of additional research to elucidate the complex interactions between ED and metabolic conditions. An integrated treatment, considering endocrinological aspects, glycemic control and cardiovascular risk factors, is crucial to improving clinical results and patients' quality of life.
 

Ler mais

INTERCONNECTIONS BETWEEN ERECTILE DYSFUNCTION AND METABOLIC DISEASES: AN INTEGRATIVE ANALYSIS

  • DOI: https://doi.org/10.22533/at.ed.1594622427063

  • Palavras-chave: Erectile Dysfunction, Metabolic Diseases, Glycemic Control.

  • Keywords: Erectile Dysfunction, Metabolic Diseases, Glycemic Control.

  • Abstract:

    Objective: To evaluate the relationship between erectile dysfunction (ED) and metabolic diseases, exploring how metabolic factors affect the occurrence of ED. Methodology: Using PVO approach, the search was conducted in the PubMed Central database. The initial selection of 44 articles was refined to14after applying the inclusion and exclusion criteria. Studies have highlighted a two-way interaction between prediabetes/type 2 diabetes (T2D) and ED, with testosterone deficiency as a common factor. Revision: Identifying ED using the International Index of Erectile Function-5 (IIEF-5) is vital for effective treatment. Therapeutic strategies include phosphodiesterase type 5 inhibitors, hormonal therapy and lifestyle changes aimed at improving erectile function and metabolic and cardiovascular control. Final Considerations: This review emphasizes the importance of additional research to elucidate the complex interactions between ED and metabolic conditions. An integrated treatment, considering endocrinological aspects, glycemic control and cardiovascular risk factors, is crucial to improving clinical results and patients' quality of life.
     

  • Bruno Cateb Resende de Oliveira
  • Gabriela Fonseca Nascimento
  • Eduarda Endlich de Freitas
  • Fernanda de Jesus Abrantes Kuriki
  • Beatriz Nahur Pimentel
  • Maria Vitória Bezerra Leite Nunes
  • GIOVANA MARCELLA
  • Alexya Millena Rolim de Araújo
  • Guilherme Silva Oliveira
  • Ana Carolina dos Reis Santos
  • Amandha Pimenta Soares
  • Priscila de Jesus Santana
Fale conosco Whatsapp